US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research
If you commercialize Molecular Diagnostics (MDx), develop Laboratory Developed Tests (LDTs), or conduct preclinical research, it is imperative that your final kit, assay, or modality adheres to exceptionally high quality standards to comply with stringent regulatory and study requirements. In the case of oligonucleotide raw materials, discover why you should consider Custom cGMP Oligos.
Manufacturing oligos under cGMP mitigates risk by minimizing the likelihood of contamination, mix-ups, deviations, failures, and other errors. This, in turn, guarantees oligo products meet the strict standards of MDx, LDTs, and preclinical research.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.